Aushon’s 2470 microarray printer provides customized solution for innovative alternative to high-throughput screening at the Broad Institute

BILLERICA, Mass.–Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis recently announced that the Eli and Edythe L. Broad Institute of MIT and Harvard will utilize Aushon’s 2470 Arrayer technology for their small molecule microarray research.

“The ability and willingness of Aushon to customize the capabilities of the 2470 Arrayer for our specific small molecule microarray application was critical,” said Angela Koehler, Ph.D., Institute Fellow of Chemical Biology at the Broad Institute. “Through our collaboration with Aushon, we were able to exploit the advanced capabilities of the 2470 microarray printing platform while adapting it to meet the stringent criteria of our own applications.”

“Our partnership with the Broad Institute resulted in a solution that will significantly impact the success of their innovative research efforts,” said Pete Honkanen, CEO of Aushon. “At the same time, it provided us with vital insights into new applications for our printing platform, and enhanced the reach and scope of our microarray technology.”

The 2470 Arrayer has been installed in leading research institutions throughout North America, Europe and Asia to provide rapid, accurate, high-density microarray printing for both genomic and proteomic applications. It is able to print virtually any sample – including cell lysates and blood – onto substrates with unique shapes and chemistries, as well as the most delicate of substrates such as nitrocellulose and silicon chips. Engineered with walk-away automation, the unique solid pin architecture and proprietary pin design make the 2470 the most flexible and reliable microarray printing platform available.

About the Broad Institute of MIT and Harvard

The Eli and Edythe L. Broad Institute of MIT and Harvard was founded in 2003 to empower this generation of creative scientists to transform medicine with new genome-based knowledge. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to www.broad.mit.edu.

About Aushon BioSystems

Aushon BioSystems provides a comprehensive suite of microarray instruments, consumables and services to leading pharmaceutical, biotechnology, academic and diagnostic clients worldwide. Our unique combination of advanced microarray printing technology, robust biomarker content and innovative multiplex immunoassay development and detection systems delivers exceptional performance, quality and reliability that accelerates pre-clinical and clinical biomarker research. Our customers trust us to provide the most reliable protein biomarker data available, which lowers costs and improves research productivity. For more information, please visit www.aushon.com.